USPTO serial 88131169
MITOQ
Reviewed by CopyMark Law Group
Reg. 5962579Status 710
- Filing date
- Status date
- Registration date
- Jan 14, 2020
- Examiner
- BILLINGS, JOHN T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with MITOQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Antipodean Pharmaceuticals, Inc.
Menlo Park, CA, US
Antipodean Pharmaceuticals, Inc.
Menlo Park, CA, US
Antipodean Pharmaceuticals, Inc.
Menlo Park, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Syed Abedi
SYED ABEDI SEED IP LAW GROUP LLP701 FIFTH AVENUESUITE 5400SEATTLE, WA 98104Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | cosmetic creams for skin care, skin cream, anti-wrinkle cream, non-medicated facial and eye serum containing mitochondrially targeted antioxidants, cosmetic preparations against sunburn, wrinkle removing skin care preparations, skin lotion, skin lighteners, skin conditioners, after sun creams, after sun moisturizers, skin and body topical lotions, creams and oils for cosmetic use | SECTION 8 - CANCELLED | — |
| 005 | pharmaceutical preparations, namely, antioxidants targeting mitochondria; dietary supplements | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Antipodean Pharmaceuticals, Inc.
- Other trademarks owned by Antipodean Pharmaceuticals, Inc.
- Other trademarks owned by Antipodean Pharmaceuticals, Inc.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named MITOQ
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 24, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 14, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 14, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 10, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 7, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Nov 19, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Nov 19, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 8, 2019 | IUAF | USE AMENDMENT FILED | — |
| Nov 8, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 21, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 26, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 26, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 6, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 15, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jan 30, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 30, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 30, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 14, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 7, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 3, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 2, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 28, 2018 | NWAP | NEW APPLICATION ENTERED | — |